NEW ORLEANS, LOUISIANA / ACCESS Newswire / November 12, 2025 / American Heart Association (“AHA”) Conference 2025, GENinCode the predictive genetics company focused on the prevention of cardiovascular ...
Promising results from a small clinical trial highlight a growing interest in designing gene-editing treatments for common ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback